140 related articles for article (PubMed ID: 3107804)
21. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
22. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
Yamit-Hezi A; Plaksin D; Eisenbach L
Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma.
Carlow DA; Kerbel RS; Feltis JT; Elliott BE
J Natl Cancer Inst; 1985 Aug; 75(2):291-301. PubMed ID: 2410653
[TBL] [Abstract][Full Text] [Related]
24. Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes.
Gelber C; Plaksin D; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1989 May; 49(9):2366-73. PubMed ID: 2784997
[TBL] [Abstract][Full Text] [Related]
25. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
26. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
27. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones.
Aboud M; Kingsmore S; Segal S
Nat Immun; 1993; 12(1):17-24. PubMed ID: 8431660
[TBL] [Abstract][Full Text] [Related]
28. Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.
Margulies DH; Evans GA; Ozato K; Camerini-Otero RD; Tanaka K; Appella E; Seidman JG
J Immunol; 1983 Jan; 130(1):463-70. PubMed ID: 6571712
[TBL] [Abstract][Full Text] [Related]
29. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
Rembecki RM; Bennett M; Kumar V; Potter TA
J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
[TBL] [Abstract][Full Text] [Related]
30. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
[TBL] [Abstract][Full Text] [Related]
32. Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor.
Garrido A; PĂ©rez M; Delgado C; Garrido ML; Rojano J; Algarra I; Garrido F
Exp Clin Immunogenet; 1986; 3(2):98-110. PubMed ID: 3274051
[TBL] [Abstract][Full Text] [Related]
33. Activation of autoreactive T-cell clones from NZB.H-2bm12 mice.
Naiki M; Yoshida SH; Ansari AA; Bill J; Gershwin ME
J Autoimmun; 1994 Jun; 7(3):275-90. PubMed ID: 7916904
[TBL] [Abstract][Full Text] [Related]
34. In vivo immunologic selection of class I major histocompatibility complex gene deletion variants from the B16-BL6 melanoma.
Talmadge JE; Talmadge CB; Zbar B; McEwen R; Meeker AK; Tribble H
J Natl Cancer Inst; 1987 Jun; 78(6):1215-21. PubMed ID: 3473258
[TBL] [Abstract][Full Text] [Related]
35. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
Henderson LA; Ciavarra R; Riblet R; Forman J
J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex.
Ozato K; Hansen TH; Sachs DH
J Immunol; 1980 Dec; 125(6):2473-7. PubMed ID: 7191868
[TBL] [Abstract][Full Text] [Related]
37. Growth and metastasis in allogeneic hosts. Lack of H-2-negative or somatic hybrid variant selection.
De Giovanni C; Lollini PL; Nicoletti G; Del Re B; Scotlandi K; Prodi G; Nanni P
Exp Clin Immunogenet; 1987; 4(3):153-62. PubMed ID: 3273420
[TBL] [Abstract][Full Text] [Related]
38. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
39. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
40. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.
de Zoeten EF; Carr-Brendel V; Cohen EP
J Immunol; 1998 Mar; 160(6):2915-22. PubMed ID: 9510195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]